Literature DB >> 25478803

Placebo responses in long-standing complex regional pain syndrome: a systematic review and meta-analysis.

Gashirai K Mbizvo1, Sarah J Nolan2, Turo J Nurmikko3, Andreas Goebel3.   

Abstract

UNLABELLED: The typical placebo response (ie, the nonspecific effects in the placebo group including benign natural course, regression to the mean, expectation/conditioning effects, and others) in randomized trials in complex regional pain syndrome (CRPS) is unknown. We recently observed a surprising near-absence of placebo response in a randomized controlled trial we conducted on patients with long-standing (≥6 months) CRPS. To investigate the idea that there may be an absence of placebo response in long-standing CRPS further, we conducted a systematic review and meta-analysis of placebo responses in randomized controlled trials conducted in patients with CRPS of ≥6 months. We systematically identified suitable randomized controlled trials published between 1966 and September 2013. We calculated the mean difference and standard error of the mean difference for placebo responses and synthesized individual effect sizes at 4 specified time periods of interest (15-30 minutes, 1 week, 3-4 weeks, and 6 weeks or more) via meta-analysis using the method of inverse-variance. Heterogeneity was assessed according to the I(2) statistic. For primary analysis, we pooled trial-specific effect sizes over the 4 time points. We analyzed data from 340 participants from 18 trials out of a possible 361 participants from 20 trials (94% of participants analyzed). Significant heterogeneity was present between trials; therefore, we interpreted trends from visual inspection of individual trials and pooled estimates. Placebo response was significant at the earliest time period (15-30 minutes). There was no significant evidence of placebo response at any of the other time periods. These results inform the design of future trials, and they caution against the "therapeutic" use of placebo in long-standing CRPS. PERSPECTIVE: In this meta-analysis of placebo responses in randomized controlled trials in long-standing CRPS, published during 1966 to 2013, we found no evidence for placebo analgesia, except at very early time points. Results inform the design of future placebo analgesia research in long-standing CRPS.
Copyright © 2015 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complex regional pain syndrome; meta-analysis; placebo response; randomized controlled trials; reflex sympathetic dystrophy

Mesh:

Year:  2014        PMID: 25478803     DOI: 10.1016/j.jpain.2014.11.008

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  6 in total

Review 1.  [Psychosocial factors in pain and pain management : A statement].

Authors:  Wolfgang Eich; Anke Diezemann-Prößdorf; Monika Hasenbring; Michael Hüppe; Ulrike Kaiser; Paul Nilges; Jonas Tesarz; Regine Klinger
Journal:  Schmerz       Date:  2022-03-18       Impact factor: 1.107

2.  Subcutaneous BoNT/A Injection for Intractable Pain and Disability in Complex Regional Pain Syndrome: A Case Report.

Authors:  Yan Tereshko; Chiara Dalla Torre; Christian Lettieri; Enrico Belgrado; Gian Luigi Gigli; Mariarosaria Valente
Journal:  Toxins (Basel)       Date:  2022-06-16       Impact factor: 5.075

Review 3.  Psycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy.

Authors:  Ángel Ortega; Juan Salazar; Néstor Galban; Milagros Rojas; Daniela Ariza; Mervin Chávez-Castillo; Manuel Nava; Manuel E Riaño-Garzón; Edgar Alexis Díaz-Camargo; Oscar Medina-Ortiz; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

Review 4.  2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.

Authors:  R Douglas Bruce; Jessica Merlin; Paula J Lum; Ebtesam Ahmed; Carla Alexander; Amanda H Corbett; Kathleen Foley; Kate Leonard; Glenn Jordan Treisman; Peter Selwyn
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

Review 5.  What Is the Role of the Placebo Effect for Pain Relief in Neurorehabilitation? Clinical Implications From the Italian Consensus Conference on Pain in Neurorehabilitation.

Authors:  Gianluca Castelnuovo; Emanuele Maria Giusti; Gian Mauro Manzoni; Donatella Saviola; Samantha Gabrielli; Marco Lacerenza; Giada Pietrabissa; Roberto Cattivelli; Chiara Anna Maria Spatola; Alessandro Rossi; Giorgia Varallo; Margherita Novelli; Valentina Villa; Francesca Luzzati; Andrea Cottini; Carlo Lai; Eleonora Volpato; Cesare Cavalera; Francesco Pagnini; Valentina Tesio; Lorys Castelli; Mario Tavola; Riccardo Torta; Marco Arreghini; Loredana Zanini; Amelia Brunani; Ionathan Seitanidis; Giuseppe Ventura; Paolo Capodaglio; Guido Edoardo D'Aniello; Federica Scarpina; Andrea Brioschi; Matteo Bigoni; Lorenzo Priano; Alessandro Mauro; Giuseppe Riva; Daniele Di Lernia; Claudia Repetto; Camillo Regalia; Enrico Molinari; Paolo Notaro; Stefano Paolucci; Giorgio Sandrini; Susan Simpson; Brenda Kay Wiederhold; Santino Gaudio; Jeffrey B Jackson; Stefano Tamburin; Fabrizio Benedetti
Journal:  Front Neurol       Date:  2018-05-18       Impact factor: 4.003

6.  A randomised, patient-assessor blinded, sham-controlled trial of external non-invasive peripheral nerve stimulation for chronic neuropathic pain following peripheral nerve injury (EN-PENS trial): study protocol for a randomised controlled trial.

Authors:  Selina Johnson; Andreas Goebel; Roberta Richey; Emily Holmes; Dyfrig Hughes
Journal:  Trials       Date:  2016-12-06       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.